Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01653678 · ClinicalTrials.gov registry record · NA
Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)
A NA study of Hypertension, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 25,875
- Enrollment target
- 1
- Study location
NCT01653678 is a NA study of Hypertension that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 25,875 participants, above the 3,452-participant average among 470 other Hypertension trials with a reported enrollment target (650% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01653678, a NA study of Hypertension, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25,875 participants
- Enrollment target
- 1
- Study location
Study Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial in 25,875 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. The VITAL Hypertension ancillary study is being conducted among participants in VITAL and will examine whether vitamin D or omega-3 fatty acids are related to changes in blood pressure and hypertension.
Conditions Studied
Interventions
- DRUG Omega-3 fatty acids (fish oil)
- DIETARY_SUPPLEMENT Vitamin D-3 (cholecalciferol), 2000 IU
- DIETARY_SUPPLEMENT Vitamin D placebo
- DRUG Fish oil placebo
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,875 participants |
| Start Date | 2011-11 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01653678
The ClinicalTrials.gov registry entry for NCT01653678 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25,875 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,452-participant average among 470 other Hypertension trials with a reported enrollment target (650% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 4 interventions - of which Omega-3 fatty acids (fish oil) is the first listed.
NCT01653678 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01653678 about?
NCT01653678 is a clinical study titled "Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)". The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is an ongoing randomized clinical trial in 25,875 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart dis...
What is the current status of trial NCT01653678?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25,875 participants. The study started on 2011-11. Estimated completion is 2026-06.
What conditions does trial NCT01653678 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT01653678?
The interventions under investigation include: Omega-3 fatty acids (fish oil) (DRUG), Vitamin D-3 (cholecalciferol), 2000 IU (DIETARY_SUPPLEMENT), Vitamin D placebo (DIETARY_SUPPLEMENT), Fish oil placebo (DRUG).
Who is sponsoring clinical trial NCT01653678?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01653678 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.